IRISH JIAN (Chief Executive Officer) sold 0.5% of their position (1.61K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2026ACC: 0001193125-26-098820
DirectorOfficer· Chief Executive Officer
Since Dec 2025
-230.07K
Net shares
Net seller
$2.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
230.07K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−228.46K
Price / share
—
Trade value
—
% of position
40.5%
12/5/2025
563.84K→335.38K
Common Stock
Direct
Shares
−1.61K
Price / share
$1.60
Trade value
$2.57K
% of position
0.5%
3/5/2026
335.38K→333.77K
Total
Net shares
−230.07K
Net value
-$2.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | G · Gift | −228.46K | — | — | 40.5% | 563.84K | 335.38K |
| Common Stock Direct | 3/5/2026 | S · Sale | −1.61K | $1.60 | $2.57K | 0.5% | 335.38K | 333.77K |
| Total | −230.07K | -$2.57K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned292.71K
Common Stock
IndirectShares owned292.71K
Total
585.43K indirect585.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 292.71K | Indirect |
| Common Stock | 292.71K | Indirect |
| Total | 585.43K | 585.43K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported